| iQone Healthcare Switzerland SA - Herzuma 150 mg, poudre pour solution à diluer pour perfusion |
| 67892 | | 02 | | Herzuma 150 mg | | poudre pour solution à diluer pour perfusion | | L01FD01 | | | | 13.07.2021 | | |
|
| Composition |
| Praeparatio cryodesiccata: trastuzumabum 150 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | poudre pour solution à diluer pour perfusion | | | | | | | | Active Agent | Dose |
|---|
| Trastuzumab | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Trastuzumab | 150 mg |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 456.84 | 513.25 | A | SL | Yes |
|
